SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 1-A/A - Offering Statement [Regulation A]: [Amend]
SEC Accession No. 0001493152-20-021920
Filing Date
2020-11-18
Accepted
2020-11-18 13:57:49
Documents
15

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 1-A/A  
1 primary_doc.xml 1-A/A 7065
2 partiiandiii.htm PART II AND III 815894
3 ex3-1.htm EX1A-3 HLDRS RTS 986
4 ex3-2.htm EX1A-3 HLDRS RTS 117038
5 ex11-1.htm EX1A-11 CONSENT 4834
6 ex12-1.htm EX1A-12 OPN CNSL 12119
7 ex3-1_001.jpg GRAPHIC 201189
8 ex3-2_001.jpg GRAPHIC 478479
9 partiiandiii_001.jpg GRAPHIC 6349
10 partiiandiii_002.jpg GRAPHIC 9248
11 partiiandiii_003.jpg GRAPHIC 17495
12 partiiandiii_004.jpg GRAPHIC 3765
13 partiiandiii_005.jpg GRAPHIC 18182
14 ex11-1_001.jpg GRAPHIC 14381
15 ex11-1_002.jpg GRAPHIC 11071
  Complete submission text file 0001493152-20-021920.txt   2006813
Mailing Address 1395 BRICKELL AVENUE SUITE 800 MIAMI FL 33131
Business Address 1395 BRICKELL AVENUE SUITE 800 MIAMI FL 33131 418-264-7134
Bioquest Corp (Filer) CIK: 0001568628 (see all company filings)

IRS No.: 990378854 | State of Incorp.: NV | Fiscal Year End: 0430
Type: 1-A/A | Act: 33 | File No.: 024-11348 | Film No.: 201324124
SIC: 2834 Pharmaceutical Preparations